ALKERMES reported 310.68M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Horizon Pharma HZNP:US $ 787.85M 96.93M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Marinus Pharmaceuticals MRNS:US $ 38.56M 7.66M
Merk MRK:US $ 9666M 666M
Minerva Neurosciences NERV:US $ 6.97M 1.02M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Otsuka Holdings 4578:JP Y 387602M 28043M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M